300639 凯普生物
已收盘 08-25 15:00:00
资讯
新帖
简况
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达3%的进展公告》
证券之星 · 08-24 03:47
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达3%的进展公告》
凯普生物(300639)8月10日股东户数3.5万户，较上期减少2.51%
证券之星 · 08-21
凯普生物(300639)8月10日股东户数3.5万户，较上期减少2.51%
凯普生物（300639）披露2026年以集中竞价交易方式回购公司股份比例达3%的进展公告，8月20日股价上涨4.83%
证券之星 · 08-20
凯普生物（300639）披露2026年以集中竞价交易方式回购公司股份比例达3%的进展公告，8月20日股价上涨4.83%
图解凯普生物中报：第二季度单季净利润同比增长154.68%
证券之星 · 08-14
图解凯普生物中报：第二季度单季净利润同比增长154.68%
凯普生物(300639)7月31日股东户数3.59万户，较上期减少0.17%
证券之星 · 08-14
凯普生物(300639)7月31日股东户数3.59万户，较上期减少0.17%
凯普生物(300639.SZ)发布上半年业绩，扭亏为盈至3126.21万元
智通财经 · 08-14
凯普生物(300639.SZ)发布上半年业绩，扭亏为盈至3126.21万元
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达2%的进展公告》
证券之星 · 08-10
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达2%的进展公告》
凯普生物(300639)7月31日股东户数3.59万户，较上期减少2.04%
证券之星 · 08-07
凯普生物(300639)7月31日股东户数3.59万户，较上期减少2.04%
凯普生物：截至2026年7月31日，公司股东总户数为35,864户
证券之星 · 08-07
凯普生物：截至2026年7月31日，公司股东总户数为35,864户
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达1%暨回购进展公告》
证券之星 · 08-05
股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达1%暨回购进展公告》
凯普生物（300639）披露回购股份比例达1%暨进展公告，8月3日股价上涨4.32%
证券之星 · 08-03
凯普生物（300639）披露回购股份比例达1%暨进展公告，8月3日股价上涨4.32%
凯普生物（300639）披露回购股份方案首次实施进展，7月28日股价上涨1.47%
证券之星 · 07-28
凯普生物（300639）披露回购股份方案首次实施进展，7月28日股价上涨1.47%
凯普生物(300639.SZ)拟7500万元至1.5亿元回购公司股份
智通财经 · 07-27
凯普生物(300639.SZ)拟7500万元至1.5亿元回购公司股份
凯普生物(300639.SZ)拟0.75亿元至1.5亿元回购公司股份
智通财经 · 07-23
凯普生物(300639.SZ)拟0.75亿元至1.5亿元回购公司股份
凯普生物（300639）披露全资子公司变更医疗器械生产许可证公告，7月21日股价下跌1.93%
证券之星 · 07-21
凯普生物（300639）披露全资子公司变更医疗器械生产许可证公告，7月21日股价下跌1.93%
凯普生物（300639）披露实际控制人增持计划完成公告，7月13日股价下跌0.96%
证券之星 · 07-13
凯普生物（300639）披露实际控制人增持计划完成公告，7月13日股价下跌0.96%
凯普生物（300639）披露公司及子公司获得发明专利授权的公告，7月1日股价上涨4.02%
证券之星 · 07-01
凯普生物（300639）披露公司及子公司获得发明专利授权的公告，7月1日股价上涨4.02%
凯普生物：6月30日董事王建瑜增持股份合计65.8万股
证券之星 · 07-01
凯普生物：6月30日董事王建瑜增持股份合计65.8万股
股市必读：凯普生物(300639)股东户数3.66万户，较上期减少1.75%
证券之星 · 07-01
股市必读：凯普生物(300639)股东户数3.66万户，较上期减少1.75%
凯普生物（300639）披露实际控制人增持计划增加集中竞价方式，6月30日股价下跌1.58%
证券之星 · 06-30
凯普生物（300639）披露实际控制人增持计划增加集中竞价方式，6月30日股价下跌1.58%
加载更多
公司概况
公司名称：
广东凯普生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-12
主营业务：
广东凯普生物科技股份有限公司的主营业务是分子诊断产品、医学检验服务、医疗大健康服务。公司的主要产品是肿瘤检测、传染病检测、妇幼健康管理、出生缺陷防控、个体化精准用药。公司系宫颈癌筛查--HPV检测的先行者、倡导者，长期深耕妇科肿瘤早筛赛道，构建了国内品类最全、技术迭代领先的HPV检测产品矩阵，持续巩固宫颈癌早筛领域龙头地位，多款核心产品具备行业标杆性优势：HPV21分型检测试剂盒是我国首个取得新药证书的HPV检测产品，核心专利荣获第十八届中国专利金奖。
发行价格：
18.39
{"stockData":{"symbol":"300639","market":"SZ","secType":"STK","nameCN":"凯普生物","latestPrice":6.15,"timestamp":1787641380000,"preClose":5.97,"halted":0,"volume":13677801,"delay":0,"changeRate":0.0302,"floatShares":630000000,"shares":647000000,"eps":-0.0157,"marketStatus":"已收盘","change":0.18,"latestTime":"08-25 15:00:00","open":5.93,"high":6.18,"low":5.89,"amount":82940500,"amplitude":0.0486,"askPrice":6.16,"askSize":2134,"bidPrice":6.15,"bidSize":392,"shortable":0,"etf":0,"ttmEps":-0.0157,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787707800000},"marketStatusCode":5,"adr":0,"adjPreClose":5.97,"symbolType":"stock","openAndCloseTimeList":[[1787621400000,1787628600000],[1787634000000,1787641200000]],"highLimit":6.57,"lowLimit":5.37,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":646500674,"isCdr":false,"pbRate":1.01,"roa":"--","roe":"0.83%","epsLYR":-0.21,"committee":-0.181419,"marketValue":3976000000,"turnoverRate":0.0217,"status":0,"floatMarketCap":3876000000},"requestUrl":"/m/hq/s/300639","defaultTab":"news","newsList":[{"id":"2661452512","title":"股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达3%的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2661452512","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661452512?lang=zh_cn&edition=full","pubTime":"2026-08-24 03:47","pubTimestamp":1787514429,"startTime":"0","endTime":"0","summary":"股本股东变化：截至2026年8月10日，凯普生物股东户数为3.5万户，较7月31日减少900户，减幅2.51%；户均持股增至1.85万股。公司公告汇总关于2026年以集中竞价交易方式回购公司股份比例达3%的进展公告截至2026年8月19日，公司已累计回购股份21,573,566股，占公司总股本的3.34%；回购最高成交价为6.32元/股，最低成交价为5.35元/股，支付资金总额为124,983,512.21元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400001505.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0046","BK0239","BK0042","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661016269","title":"凯普生物(300639)8月10日股东户数3.5万户，较上期减少2.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661016269","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661016269?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:47","pubTimestamp":1787305658,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年8月10日公司股东户数为3.5万户，较7月31日减少900.0户，减幅为2.51%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至8月10日，医疗器械行业平均股东户数为2.16万户。从股价来看，2026年7月31日至2026年8月10日，凯普生物区间涨幅为5.94%，在此期间股东户数减少900.0户，减幅为2.51%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","BK0132","300639","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660084280","title":"凯普生物（300639）披露2026年以集中竞价交易方式回购公司股份比例达3%的进展公告，8月20日股价上涨4.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660084280","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660084280?lang=zh_cn&edition=full","pubTime":"2026-08-20 22:17","pubTimestamp":1787235436,"startTime":"0","endTime":"0","summary":"截至2026年8月20日收盘，凯普生物报收于6.29元，较前一交易日上涨4.83%，最新总市值为40.66亿元。该股当日开盘6.3元，最高6.42元，最低6.15元，成交额达2.12亿元，换手率为5.34%。近日，广东凯普生物科技股份有限公司发布《关于2026年以集中竞价交易方式回购公司股份比例达3%的进展公告》。本次回购符合相关法律法规及公司回购方案的规定。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000045266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0132","BK0042","300639","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659279117","title":"图解凯普生物中报：第二季度单季净利润同比增长154.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659279117","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659279117?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:36","pubTimestamp":1786700170,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物2026年中报显示，上半年度公司主营收入3.0亿元，同比下降4.74%；归母净利润3126.21万元，同比上升134.89%；扣非净利润1213.04万元，同比上升112.69%；其中2026年第二季度，公司单季度主营收入1.74亿元，同比下降3.7%；单季度归母净利润3405.86万元，同比上升154.68%；单季度扣非净利润2193.08万元，同比上升130.95%；负债率11.32%，投资收益163.64万元，财务费用-3769.13万元，毛利率47.34%。财报数据概要请见下图:本文数据来源于凯普生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117274","title":"凯普生物(300639)7月31日股东户数3.59万户，较上期减少0.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117274","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659117274?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:33","pubTimestamp":1786699980,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年7月31日公司股东户数为3.59万户，较6月30日减少60.0户，减幅为0.17%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至7月31日，医疗器械行业平均股东户数为2.15万户。从股价来看，2026年6月30日至2026年7月31日，凯普生物区间涨幅为11.87%，在此期间股东户数减少60.0户，减幅为0.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300639","BK0132","BK0046","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659547111","title":"凯普生物(300639.SZ)发布上半年业绩，扭亏为盈至3126.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659547111","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659547111?lang=zh_cn&edition=full","pubTime":"2026-08-14 16:03","pubTimestamp":1786694587,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物 发布2026年半年度报告，报告期内，公司实现营业收入3亿元，同比下降4.74%。实现归属于上市公司股东的净利润3126.21万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1479992.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"凯普生物(300639.SZ)发布上半年业绩，扭亏为盈至3126.21万元","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","BK0042","BK0239","BK0046","300639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658366608","title":"股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达2%的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658366608","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658366608?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:22","pubTimestamp":1786299733,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，凯普生物报收于5.85元，上涨2.63%，换手率2.98%，成交量18.81万手，成交额1.08亿元。公司公告汇总：截至2026年8月7日，凯普生物累计回购股份13,322,466股，占总股本2.06%，支付资金总额74,991,008.51元。公司公告汇总关于2026年以集中竞价交易方式回购公司股份比例达2%的进展公告广东凯普生物科技股份有限公司于2026年7月23日召开第六届董事会第七次会议，审议通过以集中竞价交易方式回购公司股份的方案。截至2026年7月31日，公司股东总户数为35,864户。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0132","300639","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657611298","title":"凯普生物(300639)7月31日股东户数3.59万户，较上期减少2.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657611298","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657611298?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:40","pubTimestamp":1786095651,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯普生物披露，截至2026年7月31日公司股东户数为3.59万户，较6月18日减少745.0户，减幅为2.04%。在医疗器械行业个股中，凯普生物股东户数高于行业平均水平，截至7月31日，医疗器械行业平均股东户数为2.14万户。从股价来看，2026年6月18日至2026年7月31日，凯普生物区间涨幅为4.12%，在此期间股东户数减少745.0户，减幅为2.04%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700030403.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","300639","BK0239","BK0046","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657667959","title":"凯普生物：截至2026年7月31日，公司股东总户数为35,864户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657667959","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657667959?lang=zh_cn&edition=full","pubTime":"2026-08-07 09:12","pubTimestamp":1786065127,"startTime":"0","endTime":"0","summary":"证券之星消息，凯普生物(300639)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止到7月31日公司股东人数是多少？谢谢凯普生物回复：您好，感谢您的关注。截至2026年7月31日，公司股东总户数为35,864户。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700008973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0132","BK0046","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657458568","title":"股市必读：凯普生物新发布《关于2026年以集中竞价交易方式回购公司股份比例达1%暨回购进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657458568","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657458568?lang=zh_cn&edition=full","pubTime":"2026-08-05 01:09","pubTimestamp":1785863351,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘，凯普生物报收于5.75元，下跌0.86%，换手率2.63%，成交量16.58万手，成交额9560.12万元。公司公告汇总：截至2026年8月1日，凯普生物累计回购股份8,960,050股，占总股本的1.39%，支付资金总额50,002,536.90元。公司公告汇总关于2026年以集中竞价交易方式回购公司股份比例达1%暨回购进展公告广东凯普生物科技股份有限公司于2026年7月23日召开董事会，审议通过以集中竞价交易方式回购公司股份的方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500001489.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0239","BK0046","BK0132","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656372720","title":"凯普生物（300639）披露回购股份比例达1%暨进展公告，8月3日股价上涨4.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656372720","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656372720?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:13","pubTimestamp":1785766399,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘，凯普生物报收于5.8元，较前一交易日上涨4.32%，最新总市值为37.5亿元。该股当日开盘5.54元，最高5.84元，最低5.47元，成交额达1.52亿元，换手率为4.25%。近日，凯普生物披露《关于2026年以集中竞价交易方式回购公司股份比例达1%暨回购进展公告》。本次回购符合相关规定，公司后续将继续推进回购计划并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300036967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0132","BK0046","BK0042","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654888874","title":"凯普生物（300639）披露回购股份方案首次实施进展，7月28日股价上涨1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2654888874","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654888874?lang=zh_cn&edition=full","pubTime":"2026-07-28 22:15","pubTimestamp":1785248121,"startTime":"0","endTime":"0","summary":"截至2026年7月28日收盘，凯普生物报收于5.54元，较前一交易日上涨1.47%，最新总市值为35.82亿元。该股当日开盘5.38元，最高5.55元，最低5.3元，成交额达1.58亿元，换手率为4.6%。近日，凯普生物披露《关于2026年以集中竞价交易方式回购公司股份方案首次回购的公告》。本次回购符合法律法规及公司回购方案的规定。公司后续将根据市场情况继续实施回购计划，并及时履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072800039736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0046","BK0132","300639","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654157410","title":"凯普生物(300639.SZ)拟7500万元至1.5亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2654157410","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654157410?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:26","pubTimestamp":1785144361,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布公告，公司拟使用自有资金和银行专项回购贷款资金以集中竞价交易方式回购公司部分社会公众股份。本次回购资金总额为不低于人民币7500万元(含)且不超过人民币1.5亿元(含)，其中公司自有资金金额占比不低于10%，银行专项回购贷款资金金额占比不高于90%;回购价格不超过人民币7.84元/股(含)。本次回购实施期限为自公司董事会审议通过本次回购方案之日起不超过3个月。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472621.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300639","BK0046","BK0132","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653494677","title":"凯普生物(300639.SZ)拟0.75亿元至1.5亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2653494677","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653494677?lang=zh_cn&edition=full","pubTime":"2026-07-23 18:36","pubTimestamp":1784802979,"startTime":"0","endTime":"0","summary":"智通财经APP讯，凯普生物(300639.SZ)发布公告，公司拟使用自有资金和银行专项回购贷款资金以集中竞价交易方式回购公司部分股份，回购股份的资金总额不低于人民币7,500万元(含)，不超过人民币15,000万元(含)，回购股份的价格不超过人民币7.84元/股(含)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471506.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0042","300639","BK0132","BK0239","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653020655","title":"凯普生物（300639）披露全资子公司变更医疗器械生产许可证公告，7月21日股价下跌1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653020655","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653020655?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:41","pubTimestamp":1784644908,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，凯普生物报收于5.07元，较前一交易日下跌1.93%，最新总市值为32.78亿元。该股当日开盘5.12元，最高5.13元，最低4.85元，成交额达9229.72万元，换手率为2.92%。近日，广东凯普生物科技股份有限公司全资子公司广州凯普医药科技有限公司取得广东省药品监督管理局颁发的《医疗器械生产许可证》，生产范围变更为III类6840体外诊断试剂，许可证有效期至2027年11月16日。企业名称、住所、法定代表人、企业负责人及生产地址等信息已明确列示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045358.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","300639","BK0046","159883","BK0042","09996","BK0239","BK1574","BK0132","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651711056","title":"凯普生物（300639）披露实际控制人增持计划完成公告，7月13日股价下跌0.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651711056","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651711056?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:36","pubTimestamp":1783953380,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，凯普生物报收于5.18元，较前一交易日下跌0.96%，最新总市值为33.49亿元。近日，广东凯普生物科技股份有限公司披露《关于实际控制人之一、董事、总经理增持股份计划期限届满暨增持完成的公告》。截至公告日，王建瑜女士累计增持256.40万股，占公司总股本的0.40%，增持金额合计12,035,736.58元，增持均价为4.69元/股。增持后王建瑜女士持股比例由2.31%增至2.71%，其与一致行动人合计持股比例由32.76%增至33.15%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300040531.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","BK0132","300639","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648703541","title":"凯普生物（300639）披露公司及子公司获得发明专利授权的公告，7月1日股价上涨4.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648703541","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648703541?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:44","pubTimestamp":1782917055,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，凯普生物报收于5.17元，较前一交易日上涨4.02%，最新总市值为33.42亿元。该股当日开盘4.98元，最高5.19元，最低4.93元，成交额达7418.35万元，换手率为2.29%。近日，凯普生物及子公司获得一项关于B族链球菌分型检测的发明专利授权，专利名为“一种B族链球菌分型检测多重PCR引物和探针组合物及试剂盒”，专利号202511319804.2，授予国家为中国。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100043650.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0046","BK0239","BK0042","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648154550","title":"凯普生物：6月30日董事王建瑜增持股份合计65.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2648154550","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648154550?lang=zh_cn&edition=full","pubTime":"2026-07-01 21:02","pubTimestamp":1782910929,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月1日市场公开信息、上市公司公告及交易所披露数据整理，凯普生物（300639）最新董监高及相关人员股份变动情况：2026年6月30日公司董事,高管王建瑜共增持公司股份65.8万股，占公司总股本为0.1018%。变动期间公司股价下跌1.58%，6月30日当日收盘报4.97元。凯普生物近半年内的董监高及核心技术人员增减持详情如下：凯普生物的高管列表及最新持股情况如下：融资融券数据显示该股近5日融资净流出284.51万，融资余额减少；融券净流出5600.0，融券余额减少。该股最近90天内无机构评级。本文数据来源于深圳证券交易所信息披露、凯普生物公告，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100041559.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0046","BK0239","BK0042","BK0132"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648569231","title":"股市必读：凯普生物(300639)股东户数3.66万户，较上期减少1.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648569231","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648569231?lang=zh_cn&edition=full","pubTime":"2026-07-01 03:33","pubTimestamp":1782847991,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，凯普生物报收于4.97元，下跌1.58%，换手率1.78%，成交量11.29万手，成交额5607.71万元。股本股东变化：截至2026年6月18日股东户数为3.66万户，较6月10日减少653户，减幅1.75%。股本股东变化股东户数变动截至2026年6月18日公司股东户数为3.66万户，较6月10日减少653.0户，减幅为1.75%；户均持股数量由上期的1.74万股增加至1.77万股，户均持股市值为9.43万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100003259.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300639","BK0046","BK0132","BK0239","BK0042"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647963552","title":"凯普生物（300639）披露实际控制人增持计划增加集中竞价方式，6月30日股价下跌1.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647963552","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647963552?lang=zh_cn&edition=full","pubTime":"2026-06-30 22:27","pubTimestamp":1782829642,"startTime":"0","endTime":"0","summary":"截至2026年6月30日收盘，凯普生物报收于4.97元，较前一交易日下跌1.58%，最新总市值为32.13亿元。该股当日开盘5.05元，最高5.05元，最低4.91元，成交额达5607.71万元，换手率为1.78%。近日，广东凯普生物科技股份有限公司披露《关于实际控制人之一、董事、总经理增持股份计划增加增持方式的公告》。现为进一步增强投资者信心，增持方式增加集中竞价交易，其余计划内容不变。增持资金为自有资金，增持完成后6个月内不减持。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000047203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0042","300639","BK0046"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787652797878,"stockEarnings":[{"period":"1week","weight":-0.0293},{"period":"1month","weight":0.1076},{"period":"3month","weight":-0.0308},{"period":"6month","weight":-0.1285},{"period":"1year","weight":-0.0829},{"period":"ytd","weight":0.1097}],"compareEarnings":[{"period":"1week","weight":-0.0253},{"period":"1month","weight":0.0178},{"period":"3month","weight":-0.0635},{"period":"6month","weight":-0.064},{"period":"1year","weight":0.0147},{"period":"ytd","weight":-0.0219}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东凯普生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"34964人(较上一季度减少2.51%)","perCapita":"18024股","listingDate":"2017-04-12","address":"广东省潮州市湘桥区经济开发试验区北片高新区D5-3-3-4小区","registeredCapital":"64650万元","survey":" 广东凯普生物科技股份有限公司的主营业务是分子诊断产品、医学检验服务、医疗大健康服务。公司的主要产品是肿瘤检测、传染病检测、妇幼健康管理、出生缺陷防控、个体化精准用药。公司系宫颈癌筛查--HPV检测的先行者、倡导者，长期深耕妇科肿瘤早筛赛道，构建了国内品类最全、技术迭代领先的HPV检测产品矩阵，持续巩固宫颈癌早筛领域龙头地位，多款核心产品具备行业标杆性优势：HPV21分型检测试剂盒是我国首个取得新药证书的HPV检测产品，核心专利荣获第十八届中国专利金奖。","listedPrice":18.39},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯普生物,300639,凯普生物股票,凯普生物股票老虎,凯普生物股票老虎国际,凯普生物行情,凯普生物股票行情,凯普生物股价,凯普生物股市,凯普生物股票价格,凯普生物股票交易,凯普生物股票购买,凯普生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯普生物(300639)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯普生物(300639)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}